Fundraising FoxAxial VC — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in
BoardRohan Ganesh(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsEnsemble LabsLux CapitalObvious Ventures+5 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.